美国FDA 指导原则 产品召回，包括移除和纠正最终 英文原版.pdfVIP

Contains Nonbinding Recommendations Product Recalls, Including Removals and Corrections Guidance for Industry The FDA is issuing this guidance for immediate implementation in accordance with 21 CFR 10.115(g)(4)(i). Submit one set of either electronic or written comments on this guidance at any time. Submit electronic comments to /. Submit written comments to the Dockets Management Staff, Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852. All comments should be identified with